Skip to main content

telehealth

By Jessica Hagen | 02:00 pm | March 24, 2025
The airline will allow passengers to access medical care powered by Parsys Telemedicine in the air at "telemedicine stations."
HIMSS25
By HIMSS TV | 02:42 pm | March 05, 2025
HIMSS Media executive editors Jessica Hagen, Mike Miliard and Susan Morse discussed EMRAM Stage 7 adoption, implementing AI responsibly, workforce development, remote patient monitoring, telehealth, genomic data and precision medicine.
By Jessica Hagen | 01:44 pm | February 28, 2025
The New York-based company posted a net loss of $1 billion, or $5.87 per share, causing its stock price to fall around 15%.
By Adam Ang | 10:27 pm | February 25, 2025
Dr Ben Ng, chief medical advisor of ORA Group, explains how a hybrid model ensures the highest quality of care delivery.  
By Anthony Vecchione | 01:06 pm | November 27, 2024
The funds will be used to strengthen the company's platform with AI-driven features, increase its product development and meet rising market demand for digital healthcare.
By Jessica Hagen | 02:26 pm | September 30, 2024
A J.D. Power study indicates patients are more satisfied with payer-provided telehealth offerings and less pleased with direct-to-consumer telehealth providers compared to a year ago.
By HIMSS TV | 07:00 am | September 23, 2024
KeyCare CMO Dr. Carrie Nelson discusses how virtual care can improve acute and chronic conditions while easing clinical workload and improving patient  access, especially for seniors during winter.
By HIMSS TV | 07:00 am | September 16, 2024
Children's National Hospital, Texas Tech University Health Sciences Center, Arcare and AbleTo are facilities practicing quality telemedicine and delivering care to underserved populations, says Dr. Shawn Griffin, president and CEO at URAC.
By HIMSS TV | 07:00 am | July 02, 2024
Dr. Yusuf Sherwani, CEO and cofounder of Pelago, describes how the company partners with employers and health plans to control the costs of substance misuse disorders and the effectiveness of the virtual evidence-based treatment platform.  
By Adam Ang | 02:02 am | May 30, 2024
It is now set to take on the international markets three years after its inception.